Migraine drugs represent a small percentage of prescriptions dispensed to injured workers in California, but they make up a larger share of workers’ compensation drug payments, a new report shows.
Fewer than 1% of all prescriptions dispensed to injured California workers in 2023 were migraine drugs. However, these drugs consumed 4.7% of workers’ comp drug payments, nearly an eight-times increase since 2018, according to a California Workers’ Compensation Institute study that links to the emergence of high-cost brand drugs not listed in the Medical Treatment Utilization Schedule (MTUS) Formulary.
Migraines, a neurolo